Knights of Columbus Asset Advisors’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.9M Buy
109,712
+49,799
+83% +$6.56M 0.69% 32
2026
Q1
$8.35M Buy
59,913
+2,374
+4% +$332K 0.47% 53
2025
Q4
$7.06M Buy
57,539
+1,416
+3% +$172K 0.4% 66
2025
Q3
$6.23M Buy
56,123
+27,260
+94% +$3.1M 0.36% 78
2025
Q2
$3.2M Buy
28,863
+415
+1% +$44.2K 0.19% 127
2025
Q1
$3.19M Buy
28,448
+28,298
+18,865% +$2.92M 0.22% 121
2024
Q4
$13.9K Hold
150
﹤0.01% 358
2024
Q3
$12.6K Hold
150
﹤0.01% 373
2024
Q2
$10.3K Buy
+150
New +$10K ﹤0.01% 396
2023
Q3
Sell
-9,401
Closed -$723K 375
2023
Q2
$725K Sell
9,401
-1,239
-12% -$98.8K 0.07% 260
2023
Q1
$883K Buy
10,640
+2,759
+35% +$229K 0.09% 240
2022
Q4
$677K Sell
7,881
-87
-1% -$6.89K 0.07% 242
2022
Q3
$492K Sell
7,968
-354
-4% -$22.3K 0.05% 241
2022
Q2
$515K Sell
8,322
-115
-1% -$7.12K 0.05% 247
2022
Q1
$502K Buy
8,437
+287
+4% +$18.3K 0.04% 248
2021
Q4
$592K Buy
8,150
+2,545
+45% +$175K 0.05% 245
2021
Q3
$392K Buy
+5,605
New +$394K 0.04% 259
2019
Q4
Sell
-14,133
Closed -$896K 401
2019
Q3
$896K Buy
+14,133
New +$924K 0.34% 88
2018
Q2
Sell
-28,930
Closed -$2.18M 91
2018
Q1
$2.18M Buy
28,930
+9,100
+46% +$723K 0.99% 46
2017
Q4
$1.42M Hold
19,830
0.92% 47
2017
Q3
$1.61M Hold
19,830
1.08% 32
2017
Q2
$1.4M Hold
19,830
0.97% 42
2017
Q1
$1.35M Buy
+19,830
New +$1.39M 0.95% 45

Other funds holding GILD

Knights of Columbus Asset Advisors's GILD Position: Q2 2026 in Review

Knights of Columbus Asset Advisors increased its Gilead Sciences (GILD) stake by 83% in Q2 2026, buying an estimated $6.56M and bringing the position to 109,712 shares worth $13.9M. The position accounts for 0.69% of the portfolio, ranked #32.

Knights of Columbus Asset Advisors first reported a position in GILD in Q1 2017 and has held it in 23 quarters since. 1,412 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Knights of Columbus Asset Advisors held 109,712 shares of Gilead Sciences worth $13.9M as of Q2 2026.
  • Knights of Columbus Asset Advisors bought 49,799 Gilead Sciences shares in Q2 2026, an estimated $6.56M.
  • Gilead Sciences made up 0.69% of Knights of Columbus Asset Advisors's portfolio in Q2 2026, its #32 holding.
  • Knights of Columbus Asset Advisors first reported a position in Gilead Sciences in Q1 2017 and has held it in 23 quarters since.
  • 1,412 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Knights of Columbus Asset Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.